Stockreport

Clover Health Reports Strong Third Quarter 2024 Financial Results; Highlights Differentiated Market Opportunity to Grow Membership [Yahoo! Finance]

Clover Health Investments, Corp. - Class A Common stock  (CLOV) 
PDF Company improves 2024 year-to-date GAAP Net Loss from Continuing Operations by $117.4 million year-over-year and year-to-date Adjusted EBITDA by $87.2 million year-over [Read more]